ARMP Armata Pharmaceuticals, Inc.

Develops and commercializes novel bacteriophage-based therapeutics

$4.16
As of 04/14/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/20/2015
Outstanding shares:  24,940,442
Average volume:  28,269
Market cap:   $104,749,856
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04216R102
ISIN:        US04216R1023
Sedol:      BH3T9X8

---

Valuation   (See tab for details)

---

PE ratio:   -6.12
PB ratio:   4.16
PS ratio:   127.28
Return on equity:   -117.63%
Net income %:   -2,695.14%